GENERAL
Gland Pharma Set To Acquire Gland Pharma USA In A $5.01-Lakh Deal
Gland Pharma Ltd has approved the acquisition of 100% equity in Gland Pharma USA Inc. (Gland US), a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd., a wholly-owned subsidiary, for $5.01 lakh. Upon completion of the transaction, Gland US will become a direct wholly-owned subsidiary of Gland Pharma. The company expects to complete the […]
CW Bureau
·
Sep 13, 2026
GENERAL
Sun Pharmaceutical Agrees To MFN Pricing For US Medicaid Programmes
Sun Pharmaceutical Industries has joined several pharmaceutical companies in announcing agreements with the US government aimed at prioritising access to affordable medicines for millions of American patients. Under its agreement, Sun Pharma will extend Most Favoured Nation (MFN) pricing to state Medicaid programmes. The company has also committed to MFN pricing for future innovative medicine […]
CW Bureau
·
Sep 1, 2026
GENERAL
Aurobindo Eyes $494-Mn US Market With Launch Of Tofacitinib Generic
Aurobindo Pharma has strengthened its presence in the lucrative US generics market after receiving final approval from the US Food and Drug Administration (USFDA) for Tofacitinib tablets in 5 mg and 10 mg strengths, opening the door to a market worth nearly $500 million annually. The approval allows the company to manufacture and market a […]
CW Bureau
·
Jun 4, 2026
